A preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Cell, details a ...

Nanoparticles introduced into the bloodstream encounter the immune complement system, a proteolytic cascade that bridges innate surveillance and adaptive responses. Complement activation can occur via ...

The companies didn’t specify the drugs Biogen is acquiring in the deal, though patents RayThera secured provide important ...

Louse-borne relapsing fever is caused by the spirochete bacterium Borrelia recurrentis, which is transmitted by body lice ...

The story of Q32 Bio, a company that develops therapeutics for inflammatory and autoimmune diseases, started two decades ago. That's when V. Michael Holers, MD, a University of Colorado School of ...

The conversion from the Clinical High-Risk (CHR) stage to the onset of psychosis represents a critical period in the trajectory of psychosis [1, 2], characterized by dynamic changes in immune and ...

Arachnology and toxinology have increasingly illuminated the structural, biochemical and evolutionary diversity of venom ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Scientists are closer to understanding how an everyday painkiller can ...

Cancer remains one of the world’s leading causes of death, affecting millions of people and their families every year.

The study, published in the journal iScience, found that creatine helps activate a group of immune cells that decide whether ...

Trans-vaccenic acid (TVA), the most abundant trans fatty acid found in human breast milk, helps boost immune system ...

Louse-borne relapsing fever is an acute bacterial infection that triggers recurring episodes of high fever. It is caused by ...